The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 15, 2025
Filed:
Dec. 06, 2021
Applicant:
Sator Therapeutics, Cleveland, OH (US);
Inventors:
Peter M. Chumakov, Solon, OH (US);
Anastasia V. Lipatova, Moscow, RU;
Stepan P. Chumakov, Moscow, RU;
Natalia D. Tararova, Gates Mills, OH (US);
Stephen A. Charles, Chagrin Falls, OH (US);
Anton A. Komar, Gates Mills, OH (US);
Assignee:
SATOR THERAPEUTICS, Cleveland, OH (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/768 (2015.01); A61K 35/76 (2015.01); C12N 7/00 (2006.01); C12N 15/01 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); A61K 35/76 (2013.01); C12N 7/00 (2013.01); C12N 15/01 (2013.01); G01N 33/5011 (2013.01); C12N 2770/32321 (2013.01); C12N 2770/32332 (2013.01); C12N 2770/32351 (2013.01); G01N 2333/085 (2013.01); Y02A 50/30 (2018.01);
Abstract
Methods of inhibiting or reducing tumor growth are disclosed. A composition containing at least one selected oncolytic virus is administered within a tumor of a patient. The virus kills cancerous cells and induces a systemic and lasting anti-tumor immunity that is also compatible with other cancer treatments. Also disclosed are methods of creating synthetic viruses for targeting cancerous tumors.